HOME
PRODUCT
SOLUTION
SUPPORT
ABOUT
CONTACT
In just 10 minutes, achieve 100% confidence in your Frozen Section IHC with our innovative PolyStacker™ Technology.
Learn how to identify and target CLDN18.2 in cancer treatment. Explore the significance of CLDN18.2 and the latest advances in targeted therapies. Find insights from CAS, PubMed, and Google Scholar.
Learn how to interpret PD-L1 positive results in cancer diagnosis. Understand the role of PD-L1 and its expression in tumor growth and treatment decisions. Explore the significance of PD-L1 status in personalized medicine.